Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Cogent Biosciences, Inc.
NASDAQ:COGTHealthcare · Biotechnology
-0.32%$31.21
AH Close$31.21+0.00%vs close
AH Close$31.21+0.00%vs close
Mkt Cap$5.42B
Float149.49M
O/S173.52M
Inst Own-
SI13.0%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$328.94M
Total Assets$937.61M
Free Cash Flow-$266M
Debt & Equity
Debt 26%
Equity 65%
Preferred 9%
Total Debt$253.15M
Total Equity$636.37M
Preferred Stock$89.39M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:4Reverse splitNov 9, 20204 shares → 1
Balance Sheet Details
Assets$937.61M
Liabilities$301.24M
Accounts Receivable$0
Accounts Payable$9.5M
Inventory$0
PP&E (Net)$23.54M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $7.87M | $22.5M | $9.73M | $8.36M | $6.36M | $2.99M |
| YoY Growth | - | - | - | - | - | -65.0% | 131.1% | 16.4% | 31.5% | 112.8% | - |
| Cost of Revenue | $4.62M | $0 | $0 | $0 | $0 | $25.74M | $44K | $0 | $0 | $0 | $0 |
| Gross Profit | -$4.62M | $0 | $0 | $0 | $0 | -$17.87M | $22.46M | $9.73M | $8.36M | $6.36M | $2.99M |
| Gross Margin | - | - | - | - | - | -227.0% | 99.8% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and Development | $269.78M | $232.66M | $173.75M | $121.63M | $55.91M | $72.65M | $43.71M | $38.28M | $29.83M | $21.99M | $6.85M |
| Selling, General, and Administrative | $63.58M | $43.28M | $34.38M | $26.21M | $19.64M | $17.42M | $10.97M | $7.45M | $4.68M | $3.43M | $2.73M |
| Other | -$4.62M | $0 | $0 | $0 | $0 | -$25.74M | $78K | $320K | $274K | $0 | $0 |
| Total Operating Expenses | $328.74M | $275.94M | $208.13M | $147.84M | $75.55M | $64.33M | $54.68M | $45.74M | $34.51M | $25.43M | $9.58M |
| Operating Income (EBIT) | -$333.36M | -$275.94M | -$208.13M | -$147.84M | -$75.55M | -$82.2M | -$32.18M | -$36.01M | -$26.15M | -$19.07M | -$6.59M |
| Operating Margin | - | - | - | - | - | -1044.3% | -143.0% | -369.9% | -312.8% | -300.1% | -220.8% |
| Interest Expense | $3.06M | $0 | $0 | $3.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $14.69M | $18.09M | $13.08M | $3.99M | $467K | $144K | $267K | $1.15M | $386K | $265K | $0 |
| Other Income (Expense) | $4.43M | $20.08M | $15.72M | $7.6M | $3.28M | $7.39M | $345K | $1.47M | $660K | $946K | $0 |
| Income Before Tax (EBT) | -$328.94M | -$255.86M | -$192.41M | -$140.24M | -$72.27M | -$74.81M | -$31.83M | -$34.53M | -$25.49M | -$18.12M | -$6.59M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$328.94M | -$255.86M | -$192.41M | -$140.24M | -$72.27M | -$74.81M | -$30.27M | -$34.53M | -$25.49M | -$18.12M | -$6.59M |
| Net Income Margin | - | - | - | - | - | -950.4% | -134.6% | -354.8% | -304.9% | -285.2% | -220.8% |
| Supplementary Data | |||||||||||
| EPS | -2.04 | -2.32 | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 | -3.45 | -3.10 | -1.13 |
| Diluted EPS | -2.04 | -2.32 | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 | -3.45 | -2.45 | -0.89 |
| Weighted Average OS | 160.98M | 110.46M | 79.66M | 58.74M | 38.73M | 11.08M | 7.62M | 6.22M | 7.40M | 5.86M | 5.86M |
| EBITDA | -$321.29M | -$251.51M | -$188.82M | -$130.37M | -$72.13M | -$34.57M | -$30.89M | -$34.68M | -$24.98M | -$18.24M | -$6.41M |
| EBITDA Margin | - | - | - | - | - | -439.2% | -137.3% | -356.3% | -298.8% | -287.0% | -214.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $312.01M | $98.17M | $53.23M | $139.89M | $219.68M | $242.19M | $37.42M | $55.67M | $28.27M | $41.32M | $90.48M |
| Short-Term Investments | $588.75M | $188.91M | $212.48M | $119.39M | $0 | $0 | $0 | $22.92M | $12.69M | $27.19M | $0 |
| Cash and Short-Term Investments | $900.76M | $287.08M | $265.71M | $259.28M | $219.68M | $242.19M | $37.42M | $78.59M | $40.96M | $68.51M | $90.48M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $2M | $1.67M | $830K | $928K | $294K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $75K | $0 | $0 |
| Other Current Assets | $9.59M | $9.39M | $5.06M | $1.25M | $0 | $0 | $0 | $740K | $75K | $0 | $326K |
| Total Current Assets | $910.36M | $296.47M | $270.77M | $264.97M | $222.63M | $244.91M | $40.59M | $81M | $42.38M | $69.73M | $91.1M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $23.54M | $26.56M | $30.34M | $31.1M | $4.48M | $4.75M | $7.15M | $3.25M | $4.11M | $4.56M | $2.42M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $7.46M | $0 | $1.25M | $0 | $0 | $1.25M | $1.25M | $1.25M | $1.25M |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $3.72M | $4.86M | $4.86M | $4.75M | $3.73M | $1.25M | $1.68M | $419K | $1.37M | $0 | $0 |
| Total Long-Term Assets | $27.25M | $31.43M | $42.67M | $35.84M | $9.46M | $6M | $8.83M | $4.92M | $6.74M | $5.82M | $3.67M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $937.61M | $327.9M | $313.44M | $300.81M | $232.09M | $250.92M | $49.42M | $85.93M | $49.12M | $75.55M | $94.77M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $9.5M | $12.01M | $10.65M | $5.84M | $3.48M | $732K | $3.18M | $1.52M | $1.35M | $1.45M | $1.4M |
| Short-Term Debt | $1.55M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $1.7M | $3.06M | $0 | $1.31M | $17.95M | $6.89M | $5.96M | $5.29M |
| Other Current Liabilities | $52.9M | $12.63M | $10.31M | $6.47M | $3.62M | $7.28M | $3.39M | $3.88M | $1.64M | $118K | $606K |
| Total Current Liabilities | $63.95M | $55.71M | $38.17M | $26.85M | $17.08M | $13.09M | $13.25M | $24.95M | $11.19M | $8.74M | $7.29M |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $237.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8.71M | $13.52M | $17.3M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$14.32M | $0 | $0 | $0 | $0 | $0 | $0 | $748K | $906K | $908K | $665K |
| Total Long-Term Liabilities | $237.28M | $15.9M | $17.47M | $18.23M | $831K | $3.15M | $4.41M | $748K | $9.62M | $14.43M | $17.96M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $301.24M | $71.61M | $55.63M | $45.08M | $17.91M | $16.25M | $17.66M | $25.69M | $20.81M | $23.16M | $25.25M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $89.39M | $110.6M | $60.03M | $65.83M | $85.4M | $110.88M | $0 | $0 | $77.15M | $77.09M | $77.02M |
| Common Stock | $161K | $110K | $86K | $70K | $44K | $32K | $8K | $30K | $10K | $10K | $16K |
| Retained Earnings | -$1.19B | -$859.48M | -$603.62M | -$411.21M | -$270.97M | -$198.7M | -$123.89M | -$92.06M | -$51.34M | -$25.85M | -$7.72M |
| Comprehensive Income & Other | $355K | $447K | $246K | -$104K | -$0 | $0 | $0 | -$12K | -$16K | -$24K | -$16K |
| Other Stockholders' Equity | $1.82B | $1.12B | $861.34M | $666.88M | $485.11M | $433.33M | $155.65M | $152.26M | $79.63M | $78.22M | $77.23M |
| Total Equity | $636.37M | $256.29M | $257.8M | $255.74M | $214.18M | $234.67M | $31.76M | $60.23M | $28.3M | $52.39M | $69.52M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $937.61M | $327.9M | $313.44M | $300.81M | $232.09M | $250.92M | $49.42M | $85.93M | $49.12M | $75.55M | $94.77M |
| Supplementary Data | |||||||||||
| Total Debt | $253.15M | $17.47M | $18.85M | $19.65M | $3.15M | $5.21M | $6.03M | $0 | $0 | $0 | $0 |
| Net Debt | -$58.86M | -$80.7M | -$34.38M | -$120.24M | -$216.53M | -$236.98M | -$31.39M | -$55.67M | -$28.27M | -$41.32M | -$90.48M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$328.94M | -$255.86M | -$192.41M | -$140.24M | -$72.27M | -$74.81M | -$31.83M | -$34.53M | -$25.49M | -$18.12M | -$6.59M |
| Depreciation & Amortization | $4.58M | $4.35M | $3.59M | $5.88M | $147K | $720K | $1.29M | $1.32M | $1.17M | $830K | $179K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$236K | $17K | $17K | -$248K |
| Stock-Based Compensation | $46.08M | $39.74M | $30.62M | $18.37M | $11.69M | $6.02M | $3.24M | $3.09M | $1.34M | $1.02M | $248K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $2M | -$332K | -$838K | $98K | -$634K | -$294K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.21M | $931K | $784K | $220K |
| Accounts Payable | -$2.51M | $1.36M | $4.81M | $2.36M | $2.75M | -$2.45M | $1.66M | $367K | -$31K | $389K | $705K |
| Other Working Capital | $10.52M | $10.24M | $6.63M | -$1.61M | -$731K | -$4.87M | -$15.42M | -$3.9M | -$3.88M | -$2.86M | $23.25M |
| Total Working Capital Change | $8.01M | $11.6M | $11.44M | $751K | $2.02M | -$5.32M | -$14.08M | -$2.15M | -$2.88M | -$2.32M | $23.88M |
| Other Non-Cash Items | $5.82M | -$7.62M | -$6.87M | -$3.39M | -$343K | $37.54M | -$131K | $23K | $7K | -$56K | $248K |
| Net Cash from Operating | -$264.44M | -$207.79M | -$153.62M | -$118.64M | -$58.76M | -$35.85M | -$41.51M | -$32.49M | -$25.84M | -$18.64M | $17.72M |
| Investing Activities | |||||||||||
| Capital Expenditures | -$1.55M | -$573K | -$2.8M | -$6.86M | -$1.72M | $0 | -$33K | -$549K | -$912K | -$3.31M | -$1.99M |
| Acquisitions | $0 | $0 | $0 | $118K | $0 | $0 | $204K | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$687.17M | -$255.6M | -$348.8M | -$177.85M | $0 | $0 | $0 | -$47.68M | -$6.5M | -$55.17M | $0 |
| Sales of Investments | $289.2M | $294.45M | $253.78M | $60M | $0 | $0 | $22.99M | $37.7M | $21M | $28M | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$118K | $0 | $8.42M | $0 | $0 | -$75K | $50K | -$1.25M |
| Net Cash from Investing | -$399.53M | $38.28M | -$97.82M | -$124.72M | -$1.72M | $8.42M | $23.16M | -$10.53M | $13.51M | -$30.43M | -$3.25M |
| Financing Activities | |||||||||||
| Debt Repaid | -$215.13M | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $712M | $213.34M | $161.82M | $161.94M | $38.01M | $132.73M | $108K | $71.79M | $60K | $0 | $70.75M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$48.9M | $1.11M | $0 | $1.61M | -$30K | $560K | $0 | -$1.45M | -$789K | -$40K | $0 |
| Net Cash from Financing | $878.23M | $214.45M | $163.54M | $163.56M | $37.98M | $232.2M | $108K | $70.35M | -$729K | -$40K | $70.75M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $214.26M | $44.94M | -$87.91M | -$79.8M | -$22.51M | $204.77M | -$18.25M | $27.33M | -$13.05M | -$49.11M | $85.22M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$264.44M | -$207.79M | -$153.62M | -$118.64M | -$58.76M | -$35.85M | -$41.51M | -$32.49M | -$25.84M | -$18.64M | $17.72M |
| Capital Expenditure | -$1.55M | -$573K | -$2.8M | -$6.86M | -$1.72M | $0 | -$33K | -$549K | -$912K | -$3.31M | -$1.99M |
| Free Cash Flow | -$266M | -$208.36M | -$156.42M | -$125.5M | -$60.48M | -$35.85M | -$41.55M | -$33.04M | -$26.75M | -$21.95M | $15.72M |
| Cash at Beginning | $98.17M | $53.23M | $141.14M | $220.94M | $243.44M | $38.68M | $55.67M | $29.6M | $41.32M | $90.43M | $5.21M |
| Cash at End | $312.43M | $98.17M | $53.23M | $141.14M | $220.94M | $243.44M | $37.42M | $56.93M | $28.27M | $41.32M | $90.43M |